Author Topic: Ublituximab "reassuring" as potential relapsing MS therapy  (Read 118 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Ublituximab "reassuring" as potential relapsing MS therapy
« on: June 30, 2021, 02:47:22 pm »
From Multiple Sclerosis News Today (June 30, 2021)--"Ublituximab 'Quite Reassuring' as Potential RMS Therapy, Experts Say":


https://multiplesclerosisnewstoday.com/news-posts/2021/06/30/ublituximab-tg-therpeutics-potential-relapsing-ms-therapy-interview-article/
« Last Edit: February 28, 2023, 04:26:18 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Ublituximab up for FDA approval
« Reply #1 on: October 01, 2021, 09:04:02 pm »
From Multiple Sclerosis News Today (October 1, 2021)--"Ublituximab, Potential Relapsing MS Therapy, Up for FDA Approval":


https://multiplesclerosisnewstoday.com/news-posts/2021/10/01/tg-therapeutics-asks-fda-approval-ublituximab-relapsing-ms/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Ublituximab as relapsing MS therapy under FDA review
« Reply #2 on: December 22, 2021, 09:29:50 pm »
More on this, from Multiple Sclerosis News Today (December 15, 2021)--"Ublituximab as relapsing MS therapy under FDA review":


https://bit.ly/32dLrDm
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From Medscape Today (June 10, 2022)--"Novel drug tied to slowed disease progression in relapsing MS":


https://www.medscape.com/viewarticle/975368
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Ublituximab vs. teriflunomide in relapsing MS
« Reply #4 on: August 26, 2022, 09:35:00 pm »
From PubMed (August 25, 2022), citing a New England Journal of Medicine article, "Ublituximab versus teriflunomide in relapsing multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/36001711/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
New MS drug shows promise in trial
« Reply #5 on: September 09, 2022, 03:14:58 pm »
From WebMD (August 22, 2022)--"New MS Treatment Shows Promise in Trial":


https://wb.md/3BwD1pu
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
61 Views
Last post October 14, 2016, 12:27:50 pm
by agate
0 Replies
61 Views
Last post October 13, 2019, 09:35:32 pm
by agate
0 Replies
43 Views
Last post September 11, 2022, 08:55:48 pm
by agate
0 Replies
41 Views
Last post December 07, 2022, 10:42:38 am
by agate
0 Replies
15 Views
Last post October 30, 2023, 09:06:44 am
by agate